More articles on this subject
Previous
When Breast Cancer Comes Back: When breast cancer comes back, it can take many forms, which determines treatment, outcome, and prognosis ...
webmd.com/breast-cancer/breast-cancer-comes-back

Next
Similar to This
Previous
Understanding breast cancer recurrence: Risks, types, and management: Understanding breast cancer recurrence: Risks, types, and management
nation.africa/kenya/health/understanding-breast-cancer-recurrence-risks-types-and-management-5641530

Roche Bets on Breast Cancer Pill to Prevent Tumor Recurrence: The Swiss firm has lost its lead in the booming oncology treatment market. It’s betting on ...
bloomberg.com/news/features/2026-10-20/roche-bets-on-cancer-pill-to-prevent-breast-tumor-recurrence

Paid articlePaywallWhy breast cancer can return after treatment: The Uganda Cancer Institute (UCI), located in Mulago, Kampala, provides cancer screening, diagnosis ...
monitor.co.ug/uganda/magazines/healthy-living/why-breast-cancer-can-return-after-treatment-5634956

Paid articlePaywallTwo men were gunned down in separate shootings in New Providence last night, according to police.
'If you prosecute one, you have to prosecute all': A former member of the Water and Sewerage Corporation board insisted that prosecutions should be applied ...
thenassauguardian.com/_services/v1/client_captcha/challenge

AI tool helps predict risk of breast cancer recurrence 5 or more years after treatment
medicalnewstoday.com/articles/ai-tool-helps-predict-risk-of-breast-cancer-recurrence-5-or-more-years-after-treatment
Breast Cancer Can Return After Treatment—New Blood Test May Spot It Earlier: Recurrence is currently generally diagnosed by mammogram, ultrasound, biopsies ...
newsweek.com/breast-cancer-can-return-after-treatment-new-blood-test-may-spot-it-earlier-12362301

What COVID is teaching doctors about the relationship between viruses and cancer: "We think that these virus infections can be almost like fuel for the fire ...
pressdemocrat.com/2026/07/03/covid-doctors-viruses-cancer/

This Personalized Cancer Test Changed The Course Of My Treatment: Discover the test that helped guide one woman with her chemotherapy treatment decision.
womenshealthmag.com/health/a71083799/this-personalized-cancer-test-changed-the-course-of-my-treatment/

Breast cancer tumor vaccine being studied at Stony Brook Medicine: Stony Brook Cancer Center is one of 160 sites worldwide participating in the FLAMINGO-01 Phase ...
newsday.com/news/health/breast-cancer-tumor-vaccine-s5vycefh
What To Know About Breast Cancer Recurrence : Recurrence is when cancer returns months or years later. Early-stage breast cancer often responds well to treatment ...
health.clevelandclinic.org/early-breast-cancer-recurrence-risk
SABCS: The Drug Giredestrant Reduces the Risk of Recurrence of Dangerous Breast Cancer | NEWS.am Medicine - All about health and medicine
med.news.am/eng/news/40123/sabcs-the-drug-giredestrant-reduces-the-risk-of-recurrence-of-dangerous-breast-cancer.html

Massive cancer find on med used by millions: A cheap medicine already on the market and used by millions of people may be able to stop a type of aggressive ...
news.com.au/lifestyle/health/health-problems/triplenegative-breast-cancer-may-be-stopped-by-beta-blockers-according-to-new-research/news-story/8d4f43e777013c433e4dd83a492a29d1
Australian cancer breakthrough could end relapse for thousands, including Colette
smh.com.au/national/australian-cancer-breakthrough-could-mean-an-end-to-relapse-for-thousands-including-colette-20250804-p5mk77.html
New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
newsnetwork.mayoclinic.org/discussion/new-study-finds-triple-negative-breast-cancer-tumors-with-an-increase-in-immune-cells-have-lower-risk-of-recurrence-after-surgery/

Key FactsImmune Cells Reduce Recurrence Risk in Breast Cancer
Apr 2, 2024 · Reading time: ~45 sec.
Summary created with AI assistance · Source: newsnetwork.mayoclinic.org
Summary created with AI assistance · Source: newsnetwork.mayoclinic.org
- Early-stage triple-negative breast cancer patients with elevated tumor-infiltrating lymphocytes (TILs) show lower recurrence rates without chemotherapy.
- Nearly 2,000 participants were followed for a median of 18 years in this international study.
- TIL presence may become a standard prognostic biomarker to guide treatment decisions in TNBC.
- Detecting immune cells visually under a microscope adds no extra cost, aiding use in low-resource settings.
This is an important finding because it highlights that the abundance of TILs in breast tissue is a prognostic biomarker in people with early-stage triple-negative breast cancer, even when chemotherapy is not administered.— Roberto Leon-Ferre, M.D., a breast medical oncologist at Mayo Clinic Comprehensive Cancer Center and first author of the study.
Next